David A. Stevens
Impact in
- Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility
- Epidemiology top 0.01%
- Fungal Infections and Studies
- Nail Diseases and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Antifungal resistance and susceptibility 401
- Epidemiology 423
- Fungal Infections and Studies 354
- Nail Diseases and Treatments 111
- Pneumocystis jirovecii pneumonia detection and treatment 27
- Co-authors
- Jeff R. Dahn (44 shared papers)Karl V. Clemons (179 shared papers)David W. Denning (36 shared papers)Elmer Brummer (105 shared papers)Thomas Frost Patterson (5 shared papers)John N. Galgiani (21 shared papers)William J. Steinbach (7 shared papers)Thomas J. Walsh (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (82 papers)Medical Mycology (76 papers)Clinical Infectious Diseases (41 papers)Infection and Immunity (37 papers)Journal of The Electrochemical Society (28 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David A. Stevens
791 papers receiving 49.1k citations
David A. Stevens's Hit Papers
Peers
Comparison fields: 5 of 212
- Infectious Diseases 29.9k
- Epidemiology 25.4k
- Microbiology 604
- Small Animals 4.3k
- Microbiology 1.3k
Countries citing papers authored by David A. Stevens
This map shows the geographic impact of David A. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Stevens more than expected).
Fields of papers citing papers by David A. Stevens
This network shows the impact of papers produced by David A. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Stevens. The network helps show where David A. Stevens may publish in the future.
Co-authors
The 25 scholars most cited alongside David A. Stevens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 811 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Hit paper breakdown → | 2008 | 4304 |
| 2 | Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America Hit paper breakdown → | 2008 | 2174 |
| 3 | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2016 | 2112 |
| 4 | Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium Hit paper breakdown → | 2019 | 2112 |
| 5 | Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus Hit paper breakdown → | 2002 | 2058 |
| 6 | High Capacity Anode Materials for Rechargeable Sodium-Ion Batteries Hit paper breakdown → | 2000 | 1675 |
| 7 | The Mechanisms of Lithium and Sodium Insertion in Carbon Materials Hit paper breakdown → | 2001 | 1342 |
| 8 | Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases Hit paper breakdown → | 1990 | 827 |
| 9 | Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes Hit paper breakdown → | 2000 | 661 |
| 10 | Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial Hit paper breakdown → | 2006 | 647 |
| 11 | 2005 | 470 | |
| 12 | An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients Hit paper breakdown → | 2010 | 456 |
| 13 | 1997 | 447 | |
| 14 | 2010 | 446 | |
| 15 | 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis Hit paper breakdown → | 2016 | 436 |
| 16 | 1991 | 425 | |
| 17 | 2000 | 424 | |
| 18 | 2000 | 423 | |
| 19 | 1994 | 406 | |
| 20 | 2008 | 401 |
About David A. Stevens
David A. Stevens is a scholar working on Infectious Diseases, Epidemiology, Small Animals, Microbiology and Cell Biology, having authored 811 papers that have together received 52.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (401 papers), Fungal Infections and Studies (354 papers), Nail Diseases and Treatments (111 papers), Infectious Diseases and Mycology (62 papers), Plant Pathogens and Fungal Diseases (48 papers), Bacterial biofilms and quorum sensing (32 papers), Electrocatalysts for Energy Conversion (28 papers) and Pneumocystis jirovecii pneumonia detection and treatment (27 papers). The work is most often cited by research in Infectious Diseases (29.9k citations), Epidemiology (25.4k citations), Microbiology (604 citations), Small Animals (4.3k citations) and Microbiology (1.3k citations). David A. Stevens has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jeff R. Dahn, Karl V. Clemons, David W. Denning, Elmer Brummer, Thomas Frost Patterson, John N. Galgiani, William J. Steinbach, Thomas J. Walsh, Linda H. Hanson and John R. Wingard. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Medical Mycology, Clinical Infectious Diseases, Infection and Immunity and Journal of The Electrochemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.